Cart
sales@molnova.com
Belzutifan
CAS No. 1672668-24-4
Belzutifan( MK-6482 | PT2977 )
Catalog No. M26797 CAS No. 1672668-24-4
PT2977 is a potential treatment for clear cell renal cell carcinoma (ccRCC). PT2977 is an orally active and selective HIF-2α inhibitor (IC50: 9 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 140 | In Stock |
|
| 10MG | 260 | In Stock |
|
| 25MG | 439 | In Stock |
|
| 50MG | 644 | In Stock |
|
| 100MG | 888 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBelzutifan
-
NoteResearch use only, not for human use.
-
Brief DescriptionPT2977 is a potential treatment for clear cell renal cell carcinoma (ccRCC). PT2977 is an orally active and selective HIF-2α inhibitor (IC50: 9 nM).
-
DescriptionPT2977 is a potential treatment for clear cell renal cell carcinoma (ccRCC). PT2977 is an orally active and selective HIF-2α inhibitor (IC50: 9 nM). PT2977, as a second-generation HIF-2α inhibitor, increases potency and improves pharmacokinetic profile.(In Vitro):PT2977 effectively and dose-dependently decreased mRNA levels of human cyclin D1, a target gene regulated by HIF-2α. PT2977 reduced EPO expression in a rapid and dose-dependent manner.
-
In Vitro——
-
In Vivo——
-
SynonymsMK-6482 | PT2977
-
PathwayAngiogenesis
-
TargetHIF/HIF Prolyl-hydroxylase
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1672668-24-4
-
Formula Weight383.34
-
Molecular FormulaC17H12F3NO4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?Acetone : 50 mg/mL (130.43 mM)
-
SMILESCS(=O)(=O)c1ccc(Oc2cc(F)cc(c2)C#N)c2[C@@H](F)[C@@H](F)[C@@H](O)c12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yue QX, et al. Effects of triterpenes from Ganoderma lucidum on protein expression profile of HeLa cells. Phytomedicine. 2010 Jul;17(8-9):606-13.
molnova catalog
related products
-
TAT-cyclo-CLLFVY
Selective HIF-1 dimerization inhibitor. Blocks protein-protein interaction of recombinant HIF-1α, but not HIF-2α, with HIF-1β (IC50 = 1.3 μM). Inhibits hypoxia-induced HIF-1 activity, and decreases VEGF and CAIX expression in osteosarcoma and breast cancer cells in vitro. Also reduces tubularization of hypoxic HUVECs.
-
1,4-DPCA
1,4-DPCA is an inhibitor of prolyl-hydroxylase with an IC50 of 2.4 μM for collagen hydroxylation in human foreskin fibroblasts and 60 μM for factor inhibiting HIF (FIH).
-
Dimethyloxaloylglyci...
DMOG is an antagonist of α-ketoglutarate cofactor and inhibitor for HIF prolyl hydroxylase.
